Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein

Journal of Nutritional Science and Vitaminology

Volumn 43, Issue 4, 1997, Pages 435-444

  Hirano, Reiko ^a,b   Kondo, Kazuo ^a   Iwamoto, Tamami ^a   Igarashi, Osamu ^b   Itakura, Hiroshige ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

Antioxidant; Atherosclerosis; Oxidized LDL; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LOW DENSITY LIPOPROTEIN; PROBUCOL; RADICAL; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOOXIDATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID PEROXIDATION; NORMAL HUMAN; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0030865718     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.43.435     Document Type: Article

References (24)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. 1989. Beyond cholesterol; Modifications of low-density lipoprotein that increase its atherogenesity. N Engl J Med 320: 915-924.
2. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. 1984. Modifications of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81: 3883-3887.
3. Henriksen T, Mahoney EM, Steinberg D. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 78: 6499-6503.
4. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3: 215-222.
5. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, Fogelman AM. 1991. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 87: 2253-2257.
6. Porter NA, Caldwell SE, Mills KA. 1995. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30: 277-290.
7. Frei B, Stocker R, Ames BN. 1988. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85: 9748-9752.
8. Frei B, Gaziano JM. 1993. Content of antioxidants, performed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res 34: 2135-2145.
9. Esterbauer H, Striegl G, Puhl H, Rotheneder M. 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 6: 67-75.
10. Scheek LM, Wiseman SA, Tijburg LBM, van Tol A. 1995. Dialysis of isolated low density lipoprotein induces a loss of lipophilic antioxidants and increases the susceptibility to oxidation in vitro. Atherosclerosis 117: 139-144.
11. Kondo K, Matsumoto A, Kurata H, Tanahashi H, Koda H, Amachi T, Itakura H. 1994. Inhibition of oxidation of low-density lipoprotein with red wine. Lancet 344: 1152.
12. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT. 1986. Single vertical spin gradient ultracentrifugation. Methods Enzymol 128: 181-209.
13. Steinberg D. 1992. Antioxidants in the prevention of human atherosclerosis. Circulation 85: 2337-2344.
14. Bowry VW, Ingold KU, Stocker R. 1992. Vitamin E in human low-density lipoprotein. Biochem J 288: 341-344.
15. Mukai K, Morimoto H, Okauchi Y, Nagano S. 1993. Kinetic study of reactions between tocopheroxyl radicals and fatty acids. Lipids 28: 753-756.
16. Kalyanaraman B, Darley-Usmar V, Struck A, Hogg N, Parthasarathy S. 1995. Role of apolipoprotein B-derived radical and α-tocopheroxyl radical in peroxidase-dependent oxidation of low density lipoprotein. J Lipid Res 36: 1037-1045.
17. Niki E, Yamamoto Y, Takahashi M, Yamamoto K, Yamamoto Y, Komuro E, Miki M, Yasuda H, Mino M. 1988. Free radical-mediated damage of blood and its inhibition by antioxidants. J Nutr Sci Vitaminol 34: 507-512.
18. Sato K, Niki E, Shimasaki H. 1990. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys 279: 402-405.
19. Bowry VW, Stocker R. 1993. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 115: 6029-6044.
20. Gotoh N, Shimizu K, Komuro E, Tsuchiya J, Noguchi N, Niki E. 1990. Antioxidant activities of probucol against lipid peroxidations. Biochim Biophys Acta 1128: 147-154.
21. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84: 5928-5931.
22. Carew TE, Schwenke DC, Steinberg D. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 84: 7725-7729.
23. Barnhart RL, Busch SJ, Jackson RL. 1989. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation. J Lipid Res 30: 1703-1710.
24. McLean LR, Hagaman KA. 1990. Antioxidant activity of probucol and its effects on phase transitions in phosphatidylcholine liposomes. Biochim Biophys Acta 1029: 161-166.